Literature DB >> 22926247

Home haemodialysis and uraemic toxin removal: does a happy marriage exist?

Raymond Vanholder1, Sunny Eloot, Nathalie Neirynck, Wim Van Biesen.   

Abstract

Home-based methods of haemodialysis are becoming of increasing interest. In this article, we review theoretical and evidence-based aspects of dialysis adequacy in the home setting compared with those of standard in-centre dialysis. Owing to the flexibility it enables, home haemodialysis may allow reduced blood flow rates and the successful use of less-efficient access systems. With home haemodialysis, Kt/V(urea) targets should be pursued as recommended in current guidelines, taking into account that this parameter does not reflect a number of essential elements that affect adequacy, such as dialyser pore size or alternative timeframes-factors that might be applicable to modern home haemodialysis. The use of high-flux, large-pore haemodialysers is associated with improved removal of large uremic toxins and should be considered as standard in home haemodialysis where possible, although dialysis water purity is crucial. Large molecule removal is further enhanced by applying convective strategies (such as haemo[dia]filtration), but these strategies greatly increase technical complexity. Alternate-day haemodialysis is more desirable than the usual thrice-weekly approach to avoid complications at the end of the long weekend interval, and it is easier to implement such a regime at home than in-centre. Frequent, prolonged, and combined frequent and prolonged dialysis regimes are all associated with improved removal and improved outcomes. All three alternative timeframes are easier to apply at home than in-centre. Home haemodialysis offers increased flexibility in adopting dialysis regimes that make it possible to improve solute removal and, therefore, outcomes.

Entities:  

Mesh:

Year:  2012        PMID: 22926247     DOI: 10.1038/nrneph.2012.189

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN: 1759-5061            Impact factor:   28.314


  112 in total

Review 1.  Review on uremic toxins: classification, concentration, and interindividual variability.

Authors:  Raymond Vanholder; Rita De Smet; Griet Glorieux; Angel Argilés; Ulrich Baurmeister; Philippe Brunet; William Clark; Gerald Cohen; Peter Paul De Deyn; Reinhold Deppisch; Beatrice Descamps-Latscha; Thomas Henle; Achim Jörres; Horst Dieter Lemke; Ziad A Massy; Jutta Passlick-Deetjen; Mariano Rodriguez; Bernd Stegmayr; Peter Stenvinkel; Ciro Tetta; Christoph Wanner; Walter Zidek
Journal:  Kidney Int       Date:  2003-05       Impact factor: 10.612

2.  Long interdialytic interval and mortality.

Authors:  Cornelius J Doorenbos
Journal:  N Engl J Med       Date:  2011-12-22       Impact factor: 91.245

3.  Enhancement of convective transport by internal filtration in a modified experimental hemodialyzer: technical note.

Authors:  C Ronco; G Orlandini; A Brendolan; A Lupi; G La Greca
Journal:  Kidney Int       Date:  1998-09       Impact factor: 10.612

4.  Daily dialyses decrease plasma levels of brain natriuretic peptide (BNP), a biomarker of left ventricular dysfunction.

Authors:  Ingegerd Odar-Cederlöf; Per Bjellerup; Amy Williams; Christopher R Blagg; Zbylut Twardowski; George Ting; Carl M Kjellstrand
Journal:  Hemodial Int       Date:  2006-10       Impact factor: 1.812

5.  Mortality risk for patients receiving hemodiafiltration versus hemodialysis: European results from the DOPPS.

Authors:  B Canaud; J L Bragg-Gresham; M R Marshall; S Desmeules; B W Gillespie; T Depner; P Klassen; F K Port
Journal:  Kidney Int       Date:  2006-06       Impact factor: 10.612

6.  Reimbursement of dialysis: a comparison of seven countries.

Authors:  Raymond Vanholder; Andrew Davenport; Thierry Hannedouche; Jeroen Kooman; Andreas Kribben; Norbert Lameire; Gerhard Lonnemann; Peter Magner; David Mendelssohn; Subodh J Saggi; Rachel N Shaffer; Sharon M Moe; Wim Van Biesen; Frank van der Sande; Rajnish Mehrotra
Journal:  J Am Soc Nephrol       Date:  2012-06-07       Impact factor: 10.121

7.  Behavior of non-protein-bound and protein-bound uremic solutes during daily hemodialysis.

Authors:  Riccardo Maria Fagugli; Rita De Smet; Umberto Buoncristiani; Norbert Lameire; Raymond Vanholder
Journal:  Am J Kidney Dis       Date:  2002-08       Impact factor: 8.860

8.  The effects of nocturnal compared with conventional hemodialysis on mineral metabolism: A randomized-controlled trial.

Authors:  Michael Walsh; Braden J Manns; Scott Klarenbach; Marcello Tonelli; Brenda Hemmelgarn; Bruce Culleton
Journal:  Hemodial Int       Date:  2009-12-22       Impact factor: 1.812

9.  Long-term study of high-comorbidity ESRD patients converted from conventional to short daily hemodialysis.

Authors:  George O Ting; Carl Kjellstrand; Terri Freitas; Brian J Carrie; Shahrzad Zarghamee
Journal:  Am J Kidney Dis       Date:  2003-11       Impact factor: 8.860

10.  High dialysis dose is associated with lower mortality among women but not among men.

Authors:  Friedrich K Port; Robert A Wolfe; Tempie E Hulbert-Shearon; Keith P McCullough; Valarie B Ashby; Philip J Held
Journal:  Am J Kidney Dis       Date:  2004-06       Impact factor: 8.860

View more
  2 in total

1.  Protein-bound solute removal during extended multipass versus standard hemodialysis.

Authors:  Sunny Eloot; Wim Van Biesen; Mette Axelsen; Griet Glorieux; Robert Smith Pedersen; James Goya Heaf
Journal:  BMC Nephrol       Date:  2015-04-18       Impact factor: 2.388

2.  Free Levels of Selected Organic Solutes and Cardiovascular Morbidity and Mortality in Hemodialysis Patients: Results from the Retained Organic Solutes and Clinical Outcomes (ROSCO) Investigators.

Authors:  Tariq Shafi; Timothy W Meyer; Thomas H Hostetter; Michal L Melamed; Rulan S Parekh; Seungyoung Hwang; Tanushree Banerjee; Josef Coresh; Neil R Powe
Journal:  PLoS One       Date:  2015-05-04       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.